Deighton, C <br/><br/>
Why do the French get much greater access to anti-TNF than the British? Vive la difference? Pas necessairement.  [electronic resource] 

 -  Rheumatology (Oxford, England)  Nov 2008 
 - 1600-2 p.  digital 
<br/><br/> Publication Type: Comparative Study; Editorial; Comment 
<br/><br/><label>ISSN: </label>1462-0332 
<br/><br/><label>Standard No.: </label>10.1093/rheumatology/ken353  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--drug therapy<br/>France<br/>Guideline Adherence<br/>Healthcare Disparities<br/>Humans<br/>Patient Selection<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>United Kingdom